Chinese Hepatolgy ›› 2026, Vol. 31 ›› Issue (9): 1335-1339.

• Other Liver Diseases • Previous Articles     Next Articles

Analysis of clinical characteristics, biochemical indicators and their relationship with prognosis in neonatal cholestasis

Cai Yarong1, Yang Ning2, Ding Ya1, Wang Xiao3   

  1. 1. Department of Neonatology, Northwest Women and Children's Hospital, Xi'an 710061, China;
    2. Department of Pharmacy, the Third Affiliated Hospital of Xi'an Medical University, Xi'an 710000, China;
    3. Department of Pharmacy, Ankang Maternal and Child Health Hospital, Ankang 725000, China
  • Received:2026-02-28 Online:2026-09-30 Published:2026-11-16
  • Contact: Wang Xiao, Email: 13571420161@163.com

Abstract: Objective To identify clinical features and biochemical indices related to the prognosis of neonatal cholestasis (NC) and to evaluate their value in clinical management. Methods A total of 142 neonates diagnosed with NC in Northwest Women and Children's Hospital between January 2020 and June 2025 were enrolled and divided into an improvement group (36 cases) and a cure group (106 cases) based on discharge outcomes. Serum levels of alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamyl transferase (γ-GT), total bilirubin (TBil), direct bilirubin (DBil) and alkaline phosphatase were measured by enzymatic and diazonium methods. Binary logistic regression was used to identify factors independently associated with improvement rather than cure at discharge. Receiver operating characteristic (ROC) curves were generated to evaluate the discriminatory value of relevant indicators for cure versus improvement at discharge. Results The improvement group showed a longer disease course (30.9±3.6 vs. 26.2±3.9 days), younger gestational age (29.5±4.0 vs. 31.4±3.7 weeks), lower birth weight (1.2±0.4 vs. 1.5±0.5 kg), longer parenteral nutrition duration (35.2±4.2 vs. 31.3±4.0 days) and longer fasting duration (12.9±2.9 vs. 9.0±2.5 days) compared with the cure group (all P<0.05). The rates of bacterial infection (86.1% vs. 35.9%) and cytomegalovirus (CMV) infection (41.7% vs. 12.3%) were significantly higher in the improvement group (both P<0.05). Levels of ALT (220.3±42.7 vs. 155.8±59.1 U/L), AST (172.4±52.6 vs. 112.5±42.6 U/L), γ-GT (288.9±83.9 vs. 228.9±59.6 U/L), TBil (211.1±75.7 vs. 136.3±48.3 μmol/L) and DBil (149.9±69.8 vs. 104.0±41.1 μmol/L) were also markedly higher in the improvement group (all P<0.05). Multivariate logistic regression analysis showed that fasting duration, AST, TBil and DBil were independently associated with improvement rather than cure at discharge. The AUC values of single indicators were 0.847, 0.812, 0.795 and 0.695 respectively. Combined assessment of the four indicators yielded an AUC of 0.974, with a sensitivity of 94.4% and a specificity of 93.4%. Conclusion Disease course and parenteral nutrition duration are associated with discharge outcomes in neonates with NC. Fasting duration, AST, TBil and DBil are independent factors associated with improvement rather than cure at discharge, and their combination shows good discriminatory performance between the two outcomes.

Key words: Neonatal cholestasis, Clinical characteristics, Biochemical indicators, Prognosis